Immunoassay Biomarker Test Menu Expansion Market Report 2026

Immunoassay Biomarker Test Menu Expansion Market Overview

• Immunoassay Biomarker Test Menu Expansion market size has reached to $0.53 billion in 2025 • Expected to grow to $0.95 billion in 2030 at a compound annual growth rate (CAGR) of 12.4% • Growth Driver: Rising Prevalence Of Chronic And Lifestyle Diseases Driving Growth Of The Market Due To Increasing Demand For Early Diagnosis And Continuous Disease Monitoring • Market Trend: Innovations In Automated Immunoassay Panels Enhance Biomarker Detection Accuracy And Laboratory Efficiency • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Immunoassay Biomarker Test Menu Expansion Market?

Immunoassay biomarker test menu expansion refers to the process of increasing the range of biomarkers that can be detected and measured using immunoassay techniques. It involves developing new assays or modifying existing ones to enhance diagnostic capabilities and improve disease detection and monitoring. This expansion allows laboratories and healthcare providers to offer more comprehensive testing solutions for accurate and timely clinical decision-making. The main types of immunoassay biomarker test menu expansion include enzyme-linked immunosorbent assay kits, chemiluminescent immunoassay kits, fluorescent immunoassay kits, multiplex immunoassay panels, rapid diagnostic test kits, biomarker-specific reagents, calibration standards, and quality control materials. Enzyme-linked immunosorbent assay kits refer to antibody-based detection systems used to identify and quantify specific biomarkers in biological samples for clinical and research applications. These various biomarker types such as oncology biomarkers, cardiac biomarkers, endocrine and hormonal biomarkers, infectious disease biomarkers, autoimmune disease biomarkers, neurological biomarkers, and therapeutic drug monitoring biomarkers and they are categorized by grade such as high performance liquid chromatography and ultra high performance liquid chromatography grade reagents, gas chromatography grade reagents, analytical grade reagents, liquid chromatography–mass spectrometry grade reagents, preparative grade reagents, biotechnology grade reagents, and technical grade filtration products. The various applications involved are clinical diagnostics, companion diagnostics, personalized medicine, and drug discovery and clinical research, and they are used by several end users such as pharmaceutical and biotechnology companies, contract research organizations, contract manufacturing organizations, academic and research institutions, clinical and diagnostic laboratories, food and beverage testing laboratories, environmental testing laboratories, government and regulatory agencies, and chemical and industrial manufacturing companies.

What Is The Immunoassay Biomarker Test Menu Expansion Market Growth Forecast?

The immunoassay biomarker test menu expansion market size is expected to see rapid growth in the next few years.It will grow to $0.95 billion by 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to rising demand for precision medicine and personalized biomarker profiling, increasing integration of AI and automation in diagnostic laboratories, expansion of companion diagnostics in drug development pipelines, growing adoption of multiplex and high throughput testing platforms, increasing focus on early cancer and chronic disease detection programs.Major trends in the forecast period include expansion of multiplex immunoassay panels for multi biomarker disease detection, increasing development of high sensitivity chemiluminescent immunoassay platforms, rising adoption of personalized medicine driven biomarker testing solutions, growing integration of automated laboratory immunoassay analyzers for high throughput testing, increasing demand for oncology and infectious disease biomarker assay expansion.

Global Immunoassay Biomarker Test Menu Expansion Market Segmentation

1) By Type: Enzyme-Linked Immunosorbent Assay Kits, Chemiluminescent Immunoassay Kits, Fluorescent Immunoassay Kits, Multiplex Immunoassay Panels, Rapid Diagnostic Test Kits, Biomarker-Specific Reagents, Calibration Standards, Quality Control Materials 2) By Biomarker Type: Oncology Biomarkers, Cardiac Biomarkers, Endocrine And Hormonal Biomarkers, Infectious Disease Biomarkers, Autoimmune Disease Biomarkers, Neurological Biomarkers, Therapeutic Drug Monitoring Biomarkers 3) By Grade: High-Performance Liquid Chromatography (HPLC) And Ultra-High-Performance Liquid Chromatography (UHPLC) Grade Reagents, Gas Chromatography (GC) Grade Reagents, Analytical Grade Reagents, Liquid Chromatography–Mass Spectrometry (LC-MS) Grade Reagents, Preparative Grade Reagents, Biotechnology Grade Reagents, Technical Grade Filtration Products 4) By Application: Clinical Diagnostics, Companion Diagnostics, Personalized Medicine, Drug Discovery And Clinical Research 5) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Contract Manufacturing Organizations, Academic And Research Institutions, Clinical And Diagnostic Laboratories, Food And Beverage Testing Laboratories, Environmental Testing Laboratories, Government And Regulatory Agencies, Chemical And Industrial Manufacturing Companies Subsegments: 1) By Enzyme-Linked Immunosorbent Assay Kits: Sandwich Assay Kits, Competitive Assay Kits, Indirect Assay Kits, Direct Assay Kits 2) By Chemiluminescent Immunoassay Kits: Magnetic Particle-Based Kits, Solid Phase Kits, Microplate-Based Kits, Automated Analyzer Kits 3) By Fluorescent Immunoassay Kits: Time-Resolved Fluorescence Kits, Lateral Flow Fluorescence Kits, Microbead-Based Kits, Multiplex Fluorescence Kits 4) By Multiplex Immunoassay Panels: Cytokine Panels, Cardiac Marker Panels, Oncology Panels, Infectious Disease Panels 5) By Rapid Diagnostic Test Kits: Lateral Flow Immunoassays, Colloidal Gold Test Kits, Microfluidic Rapid Kits, Paper-Based Diagnostic Kits 6) By Biomarker-Specific Reagents: Antibodies, Antigens, Conjugates, Detection Reagents 7) By Calibration Standards: Protein Standards, Peptide Standards, Whole Blood Controls, Serum Controls 8) By Quality Control Materials: Positive Controls, Negative Controls, Internal Controls, External Controls

What Is The Driver Of The Immunoassay Biomarker Test Menu Expansion Market?

The increasing prevalence of chronic and lifestyle diseases is expected to propel the growth of the immunoassay biomarker test menu expansion industry going forward.Chronic and lifestyle diseases are long-term health conditions such as heart disease, diabetes, obesity, and hypertension that persist over time and require ongoing medical attention.The prevalence of these diseases is increasing due to aging populations and lifestyle risk factors such as poor diet and physical inactivity, which have raised the overall burden of chronic health conditions.Immunoassay biomarker test menu expansion supports greater disease detection by enabling laboratories to identify a wider range of disease-associated biomarkers, improving early diagnosis and monitoring.For instance, in April 2025, according to the US Centers for Disease Control and Prevention, a US-based government public health agency, in 2023, 76.4% of US adults reported at least one chronic condition, representing more than 194 million adults with ongoing health conditions that require regular monitoring and management.Therefore, the rising prevalence of chronic and lifestyle diseases is driving the growth of the immunoassay biomarker test menu expansion industry.

Key Players In The Global Immunoassay Biomarker Test Menu Expansion Market

Major companies operating in the immunoassay biomarker test menu expansion market are Tecan Trading AG, Euroimmun Medizinische Labordiagnostika AG, OPKO Health Inc., Autobio Diagnostics Co. Ltd., Promega Corporation, BioLegend Inc., Sekisui Diagnostics LLC, Boditech Med Inc., Dynex Technologies Inc., QuantuMDx Group Ltd., NanoEntek, J. Mitra & Co. Pvt. Ltd., Baebies, ALPCO Diagnostics, Micropoint Bioscience, Coris BioConcept, MiCo BioMed Inc., Kamiya Biomedical Company, Abionic SA, ANP Technologies Inc., Axis‑Biosciences / Axela, Epitope Diagnostics Inc., MedMira Inc., Nanōmix Inc.

Global Immunoassay Biomarker Test Menu Expansion Market Trends and Insights

Major companies operating in the immunoassay biomarker test menu expansion market are focusing on developing advanced automated immunoassay panels, such as fully integrated immunoassay systems that streamline sample handling and result reporting within a single automated workflow, to reduce operator variability and increase laboratory throughput. Automated immunoassay panels are systems in which immunoassay tests are performed with minimal manual intervention through robotics or automated analyzers that manage sample preparation, reagent mixing, incubation, detection, and result output, improving consistency and turnaround time in clinical settings. For instance, in May 2024, bioMérieux, a France-based healthcare technology company, launched the VIDA TBI (GFAP, UCH-L1) test for its automated immunoassay platforms VIDAS 3 and VIDAS KUBE, featuring high sensitivity for traumatic brain injury biomarkers, compatibility with on-demand automated workflows 24/7, and rapid result turnaround, aiding efficient clinical triage and reducing unnecessary imaging. The launch strengthens bioMérieux’s immunoassay test menu by expanding its neurological biomarker portfolio and addressing growing demand for rapid diagnostic solutions in emergency care settings. Additionally, it supports improved clinical decision-making by enabling timely and accurate detection of brain injury, enhancing patient management, and optimizing healthcare resource utilization.

What Are Latest Mergers And Acquisitions In The Immunoassay Biomarker Test Menu Expansion Market?

In July 2024, Roche, a Switzerland-based healthcare technology company, acquired LumiraDx’s point-of-care technology business for an agreed purchase price of approximately $295 million plus up to $55 million in additional payments. With this acquisition, Roche aims to broaden its diagnostics portfolio by integrating a multi-assay point-of-care platform that consolidates immunoassay, clinical chemistry, and related tests, expanding access to decentralized diagnostic solutions and accelerating global testing capabilities in primary care. LumiraDx is a UK-based healthcare technology company that specializes in providing an advanced point-of-care diagnostic platform capable of running a wide range of immunoassay and clinical chemistry tests on a single instrument, with potential for further molecular testing expansion.

Regional Insights

North America was the largest region in the immunoassay biomarker test menu expansion market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Immunoassay Biomarker Test Menu Expansion Market?

The immunoassay biomarker test menu expansion market consists of sales of enzyme-linked immunosorbent assay kits, chemiluminescent immunoassay kits, fluorescent immunoassay kits, multiplex immunoassay panels, rapid diagnostic test kits, biomarker-specific reagents, calibration standards, and quality control materials. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

What is the Market Assessment and Strategic Outlook for the Immunoassay Biomarker Test Menu Expansion Industry?

The immunoassay biomarker test menu expansion market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the immunoassay biomarker test menu expansion industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

What is the Market Assessment and Strategic Outlook for the Immunoassay Biomarker Test Menu Expansion Market Report 2026?

The immunoassay biomarker test menu expansion market research report is one of a series of new reports from The Business Research Company that provides immunoassay biomarker test menu expansion market statistics, including immunoassay biomarker test menu expansion industry global market size, regional shares, competitors with a immunoassay biomarker test menu expansion market share, detailed immunoassay biomarker test menu expansion market segments, market trends and opportunities, and any further data you may need to thrive in the immunoassay biomarker test menu expansion industry. This immunoassay biomarker test menu expansion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.